Tag: Brain Cancer

The NPPA Sets a Price Cap on Nine Planned Formulations, one of which is a Medication for Brain Cancer

Nine more formulations have had their ceiling prices set by the National Pharmaceutical Pricing Authority (NPPA), bringing the total number of formulations notified with updated prices under the Drugs (Prices Control) Order (DPCO), 2013—a revised Schedule I based on the National List of Medicines (NLEM), 2022—to 700.

Back to top

Registration Form


This will close in 0 seconds

This will close in 0 seconds

WhatsApp Join Telegram